Why the study?
Prehospital delay in ACS is driven by delays in early detection and inaccurate early treatment, presenting an opportunity for smartphone applications like DETAK to facilitate education.
Does education through the DETAK mobile application improve the ability of early detection and early treatment of ACS in high-risk individuals?
Does education through the DETAK mobile application improve the ability of early detection and early treatment of ACS in high-risk individuals?
The DETAK mobile application significantly improves the ability of high-risk individuals to early detect and treat acute coronary syndrome compared to conventional leaflets.
Answers are grounded in this paper and cite their sources.
Supports DETAK app integration into ACS education for high-risk patients; extends RCT evidence for mobile health interventions in cardiovascular prevention.
Introduction: Acute Coronary Syndrome (ACS) is still a major cause of mortality and morbidity globally. One of the factors that cause a prehospital delay is the delay in early detection and inaccuracy of early treatment of ACS. The Internet of Things, which is supported by the high use of smartphones with the DETAK application, can be an opportunity to facilitate ACS education programs so that ACS can be detected early. Method: This study has used a quantitative research design with a quasi-experimental approach which pretest and posttest, in which both the experimental and control groups participate. The inclusion criteria of this study were age >45 years; obesity; smoker; Respondents with a history of: hypertension/diabetes mellitus/hyperlipidemia/hypercholesterolemia/CVD/families with cardiovascular disease. 252 respondents who met the inclusion criteria were randomly divided into control (n=126) and intervention groups (n=126). The intervention group was given education through the DETAK application and the control group was given leaflet about ACS. Results: The results of the study showed that there was an increased in early treatment ability was only found in the intervention group (p<.001). Mean differences of the ability of early detection (p<.001) and early treatment (p=.019)between intervention and control groups were both significance. Conclusion: There is potential for DETAK applications to improve the early detection and treatment capabilities of ACS.
No takes yet. Share an insight, caveat, or question.
Anggraini et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: